Moderators:  Charles M. Perou, PhD, University of North Carolina, Chapel Hill, NC and Michael Stratton, FRCPath, FMCDSCI, FRS, The Wellcome Trust Sanger Institute, Hinxton, Cambridge, UNITED KINGDOM

TCGA breast cancer sequencing: Results and interpretation
Elaine R. Mardis, PhD
Washington University
St. Louis, MO

Diverse patterns of mutation in breast cancer genomes
Michael Stratton, FRCPath, FMCDSCI, FRS
The Wellcome Trust Sanger Institute
Hinxton, Cambridge, UNITED KINGDOM

Integrative genomic analyses of breast cancer from The Cancer Genome Atlas (TCGA)
Chad J. Creighton, PhD
Baylor College of Medicine
Houston, TX

Epigenomic data analysis of TCGA breast cancer samples
Peter W. Laird, PhD
USC Epigenome Center
Los Angeles, CA

The DNA copy number landscapes and genomic architecture: Relevance for progression and outcome
Anne-Lise Børresen-Dale, PhD, MD (h.c.)
Oslo University Hospital

Oslo, NORWAY

Genomic analyzes for pathway characterization
David Haussler, PhD
University of California, Santa Cruz
Santa Cruz, CA

Moderator:  C. Kent Osborne, MD, Baylor College of Medicine, Houston, TX

Advances in basic breast cancer research
Kornelia Polyak, MD, PhD
Dana-Farber Cancer Institute
Boston, MA

Translational breast cancer research
Andrea Richardson, MD, PhD
Dana-Farber Cancer Institute
Boston, MA

Early breast cancer
Nancy E. Davidson, MD
University of Pittsburgh Cancer Institute
Pittsburgh, PA

Challenges and success: Treatment of metastatic breast cancer 2011
Hope S. Rugo, MD
University of California, San Francisco
San Francisco, CA